Post Marketing Surveillance of Remicade in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Patients.
Phase of Trial: Phase IV
Latest Information Update: 28 Oct 2013
At a glance
- Drugs Infliximab (Primary)
- Indications Ankylosing spondylitis; Psoriasis; Psoriatic arthritis; Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Schering-Plough
- 10 Jun 2017 Biomarkers information updated
- 20 Jun 2012 Actual patient numbers amended from 125 to 1055 as reported by ClinicalTrials.gov.
- 20 Jun 2012 Actual end date changed from May 2011 to Apr 2011 as reported by ClinicalTrials.gov.